Portfolio Trading Pattern
Greetings to all. The previous
report on Edison is not successful because the title did not pass (through) the price (* Buy Limit) indicated.
MolMed : Title pharmaceuticals that could benefit from the +40% occurred Friday on the Nasdaq, to \u200b\u200b" Cell Therapeutics."
0 comments:
Post a Comment